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Annabelle L. Frost, BMBS; Satish Adwani; Kenny McCormick; Paul Leeson , PhD
BACKGROUND: Pregnancy complications such as preterm birth and fetal growth restriction are associated with altered prenatal 
and postnatal cardiac development. We studied whether there were changes related specifically to pregnancy hypertension.
METHODS AND RESULTS: Left and right ventricular volumes, mass, and function were assessed at birth and 3 months of age by 
echocardiography in 134 term- born infants. Fifty- four had been born to mothers who had normotensive pregnancy and 80 
had a diagnosis of preeclampsia or pregnancy- induced hypertension. Differences between groups were interpreted, taking 
into account severity of pregnancy disorder, sex, body size, and blood pressure. Left and right ventricular mass indexed to 
body surface area (LVMI and RVMI) were similar in both groups at birth (LVMI 20.9±3.7 versus 20.6±4.0 g/m2, P=0.64, RVMI 
17.5±3.7 versus 18.1±4.7 g/m2, P=0.57). However, right ventricular end diastolic volume index was significantly smaller in those 
born to hypertensive pregnancy (16.8±5.3 versus 12.7±4.7 mL/m2, P=0.001), persisting at 3 months of age (16.4±3.2 versus 
14.4±4.8 mL/m2, P=0.04). By 3 months of age these infants also had significantly greater LVMI and RVMI (LVMI 24.9±4.6 
versus 26.8±4.9 g/m2, P=0.04; RVMI 17.1±4.2 versus 21.1±3.9 g/m2, P<0.001). Differences in RVMI and right ventricular end 
diastolic volume index at 3 months, but not left ventricular measures, correlated with severity of the hypertensive disorder. No 
differences in systolic or diastolic function were evident.
CONCLUSIONS: Infants born at term to a hypertensive pregnancy have evidence of both prenatal and postnatal differences in 
cardiac development, with right ventricular changes proportional to the severity of the pregnancy disorder. Whether differences 
persist long term as well as their underlying cause and relationship to increased cardiovascular risk requires further study.
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Infants born to mothers who have had hyperten-sive disorders of pregnancy are at increased risk of cardiovascular events1 and clinical hypertension1,2 
later in life. The rise in blood pressure is evident from 
childhood and increases into adulthood,3 so that by 
20 years of age up to 30% of young adults who have 
clinical hypertension have a background history of ma-
ternal pregnancy hypertension.4
The increased risk may in part relate to differences 
in vascular phenotype observed in the offspring. During 
the first few months of life, their vascular cells have re-
duced angiogenic function and the changes predict 
the efficiency of their postnatal microvascular develop-
ment.5–7 Differences are also evident in the pulmonary 
circulation with altered pulmonary vascular responses 
in later life.8,9 Whether hypertensive pregnancy also re-
lates to differences in offspring cardiac development 
is less clear. Most studies have been in adolescents, 
and focused on the left ventricle, with reports of no 
differences in mass10,11 or hypertrophy proportional 
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to variation in blood pressure.12 We have previously 
demonstrated an association between preterm birth 
and cardiac structure and function,13,14 with differences 
emerging during early postnatal life.15 This alteration in 
cardiac development was seen irrespective of whether 
the infant was born after hypertensive or normoten-
sive pregnancy but there appeared to be a potential, 
additional impact of maternal hypertension on cardiac 
development.15
Therefore, we have now explored the specific as-
sociation of maternal hypertension with prenatal and 
postnatal cardiac development, by studying term- 
born individuals, without other pregnancy complica-
tions, and before development of significant changes 
in blood pressure. We then explored whether particu-
lar clinical features of the maternal hypertensive disor-
der were associated with changes in cardiac structure 
or function. Our hypothesis was that maternal hyper-
tension would be associated with unique cardiac 
remodeling in the offspring in the first 3  months of 
postnatal life compared with infants born to normo-
tensive pregnancies.
METHODS
The data that support the findings of this study, in-
cluding more detail on the Methods and Materials, are 
available in the Supplementary Materials or from the 
corresponding author upon reasonable request.
Study Overview
Between 2011 and 2015, mothers being cared for by 
the Oxford University Hospitals NHS Foundation Trust 
were identified by their clinical care team and invited to 
take part in 1 or more of a portfolio of studies coordi-
nated by the Oxford Cardiovascular Clinical Research 
Facility. These studies were designed to investigate 
the impact of pregnancy complications on cardio-
vascular development during fetal and neonatal life. 
The EPOCH (Effect of Preterm Birth and Pregnancy 
Hypertension on Offspring Cardiovascular Health) 
study5 was a prospective cohort study investigating 
the effects of prematurity and hypertensive disorders 
of pregnancy on the cardiovascular development of 
the offspring. Ethical approval was granted by the 
South Central Berkshire Research Ethics Committee 
(reference 11/SC/0006), and the trial registered with 
ClinicalTrials.gov (reference number NCT01888770). 
A stratified recruitment strategy was used so that the 
5 study groups (normotensive term, normotensive 
preterm, preeclampsia term, pregnancy- induced hy-
pertension term, and hypertensive preterm) had ap-
proximately equal numbers (Figure 1).
Inclusion and Exclusion Criteria
Singletons and multiplets were included. Mothers 
below the age of 16  years were excluded from the 
study as were those with chronic cardiovascular 
CLINICAL PERSPECTIVE
What Is New?
• We showed that at birth, term-born infants ex-
posed to a hypertensive pregnancy had a sig-
nificantly smaller right ventricular end diastolic 
volume.
• At 3 months of age, these infants also had sig-
nificantly greater right and left ventricular mass 
indexed to body surface area.
• Changes in right ventricular mass and end dias-
tolic volume between birth and 3 months corre-
lated with severity of the hypertensive disorder.
What Are the Clinical Implications?
• Our findings of a disproportionate increase in 
cardiac mass in infants born to hypertensive 
pregnancies are consistent with some prior ob-
servations in older populations.
• This raises the possibility that differences in 
later life may be because of distinct trajectories 
for cardiovascular growth, which start in the first 
few months of life and precede the development 
of significant hypertension.
• Early postnatal life may represent a critical win-
dow for cardiac development, and optimization 
of perinatal care may reduce the long-term car-
diovascular sequelae in this cohort.
Nonstandard Abbreviations and Acronyms
ASD atrial septal defect
CCRF  Oxford Cardiovascular Clinical Research 
Facility
EDV end diastolic volume
EPOCH  Effect of Preterm Birth and Pregnancy 
Hypertension on Offspring Cardiovas-
cular Health
LV left ventricular
LVMI left ventricular mass index
NHS National Health Service
PDA patent ductus arteriosus
RV right ventricular
RVMI right ventricular mass index
RVEDVI  right ventricular end diastolic volume 
index
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conditions prenatally, including essential hypertension. 
Infants were excluded if they had evidence of any se-
vere malformations, congenital cardiovascular disease, 
chromosomal abnormalities, or genetic disorders, but 
those with persistent features of a fetal circulation at 
birth (ie, patent ductus arteriosus (PDA) and/or atrial 
septal defect (ASD) were included.
Neonatal Cohort Selection and Imaging 
Assessments
This exploratory study was a secondary analy-
sis to specifically look at the effect of exposure 
to a hypertensive pregnancy on term- born ba-
bies. Echocardiography data were used from 
Figure 1. An overview of the study cohort and design.
A. An overview of the study cohort. B. Postnatal echocardiography was performed in the cohort of 
term infants at birth and 3 months of age in order to investigate the effects of maternal hypertension on 
cardiac structure and function and their association with other maternal and perinatal characteristics. BMI 
indicates body mass index; EPOCH, Effect of Preterm Birth and Pregnancy Hypertension on Offspring 
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measurements at birth and 3 months of age in infants 
born after 37  weeks’ gestation who participated in 
the EPOCH study.5 All mothers gave written informed 
consent, and assent for involvement of their children, 
including permission to access maternal and off-
spring clinical records. Figure 1 outlines an overview 
of the study design. Inclusion and exclusion criteria 
as well as data collection methods and clinical char-
acterization have been previously reported5 and are 
reported briefly in Data S1. Definitions of preeclamp-
sia and pregnancy- induced hypertension were based 
on standard definitions of the International Society 
for the Study of Hypertension in Pregnancy.16 Those 
in the normotensive group were required to have had 
blood pressure <140/90 mm Hg at each pregnancy 
visit without a previous history of hypertension or hy-
pertension in other pregnancies. Women with essen-
tial hypertension were excluded from the study.
Echocardiography
Imaging was performed with a S12- 4 transducer at-
tached to a Phillips CX50 at birth and a Philips iE33 at 
3 months of age. At each time point, a 2- dimensional 
transthoracic echocardiography protocol that in-
cluded acquisition of a 4- chamber view optimized 
for the left ventricle (LV) was performed according 
to standard guidelines.17 Postnatal measures were 
performed in a temperature- controlled room, with 
the infant at rest in a semirecumbent position at 45°, 
either in the arms of their mother, or a crib. To opti-
mize images for postprocessing sector width, gains 
and depth were altered to maximize frame rate and 
multiple images were acquired for offline selection of 
highest quality loops. We used TomTec Image Arena 
4.6 to create automated volumetric estimates of LV 
mass based on endocardial and epicardial borders 
defined in multiple 4- chamber cine loops. An adapta-
tion of the method was applied to the right ventricle 
(RV), as previously reported.18 Images were deemed 
analyzable if the endo- and epicardial border of the 
ventricle could be seen clearly in its entirety dur-
ing the whole cardiac cycle. Detailed methods and 
our laboratory inter- and intraobserver variability for 
measures are described in Data S1.
Statistical Analysis
Statistical analysis was performed using SPSS 
Version 22 (IBM, Armonk, NY) and GraphPad Prism 
6.0 (La Jolla, CA,). To compare mean differences in 
cardiac size postnatally, a Student t test and Mann–
Whitney U test were used as appropriate. Tests 
of associations were performed using a χ2 test. 
Bonferroni corrections were used for multiple group 
comparisons. Simple linear regression models were 
performed between measures of cardiovascular 
structure and function and each of maternal, off-
spring, and pregnancy covariates. Those covariates 
that were significant at the 5% level were included 
in a multiple linear regression (maternal age was ad-
justed for regardless of statistical significance). When 
both systolic and diastolic blood pressure were sig-
nificant in the bivariate regression models because 
of multicollinearity, only systolic blood pressure was 
used in the multiple regression. Values are presented 
as mean±SD unless stated otherwise. Bar charts are 




Maternal and offspring demographic and anthropo-
metric characteristics in the normotensive and hy-
pertensive groups are presented in Table 1. Mothers 
who experienced a hypertensive pregnancy had a 
higher bone mineral density and a higher systolic 
and diastolic blood pressure at their booking antena-
tal visit (usually between 8 and 12 weeks’ gestation). 
The mean of the maximum blood pressure during 
pregnancy for mothers diagnosed with a hyperten-
sive pregnancy was 158±12  mm  Hg (systolic) and 
99±7 mm Hg (diastolic). The mean gestational age at 
diagnosis was 37.3±3.1 weeks’ gestation. Of the 80 
hypertensive women, 57 required treatment with an-
tihypertensive medication during pregnancy (36 were 
on labetalol alone, 3 on nifedipine alone, and 18 were 
on 2 different agents). Although babies born preterm 
were excluded, those born to hypertensive pregnan-
cies were born on average 3 days earlier and had on 
average a 1- cm smaller head circumference at birth. 
Subgroup analysis demonstrated these differences 
related to being born to preeclamptic pregnancies 
and were not evident in those whose mothers had 
pregnancy- induced hypertension (Table S1). Infants 
from a preeclamptic pregnancy were also found to 
be lighter and had a lower birthweight z- score than 
those born to mothers with pregnancy- induced hy-
pertension or normotensive pregnancies. Of note, 
there were no differences in blood pressure between 
groups either at birth or 3  months of age (Table  1 
and Table S1). All 134 infants had echocardiography 
data from at least 1 time point. Images were deemed 
analyzable if the endo- and epicardial border of the 
ventricle could be seen clearly in its entirety dur-
ing the whole cardiac cycle. Echocardiography was 
performed at birth in 122 infants, of which LV meas-
ures were possible in 117 (4 unanalyzable because 
of infant movement, 1 excluded because of subse-
quent diagnosis of Turner’s syndrome). One hundred 
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which 110 had analyzable images. Image acquisition 
was optimized for LV assessment but, of the avail-
able scans at birth, 76 had analyzable RV views with 
75 infants having measures at follow- up.
LV and RV Structure and Function at Birth 
and 3 Months of Age
Infants born to a hypertensive pregnancy had a similar 
LV mass at birth, compared with those born to normo-
tensive pregnancies, with no differences in LV mass 
indexed to body surface area or EDV. LV EDV was 
smaller but the difference was no longer significant 
when adjusted for body size and, at 3 months of age, 
no significant differences in LV volume were evident. 
However, LV mass indexed to either body size or ven-
tricular volume was significantly increased in the group 
born to a hypertensive pregnancy at 3 months of age. 
This was not correlated with infant blood pressure ei-
ther at birth or at 3 months of age. No differences in LV 
function were observed either at birth or 3 months of 
age (Figure 2A, Table S2). Infants born to a hyperten-
sive pregnancy had similar RV mass indexed to body 
surface area at birth. However, RV EDV was smaller at 
birth in this group and this persisted when adjusted for 
body size. As a result, RV mass indexed to EDV was 
also higher (Figure 2B, Table S2). At 3 months of age 
both RV mass indexed to body surface area and in-
dexed to EDV were significantly greater and RV volume 
remained significantly smaller (Figure 2B, Table S2). No 
differences in RV function were observed at either time 
point (Table S2).
Associations Between Maternal 
Pregnancy Characteristics and Infant 
Cardiac Changes
Body surface area at birth and at 3 months of age cal-
culated using the Boyd formula19 was not associated 
with RV mass change over this time period. Body 
surface area at 3 months of age was also not associ-
ated with LV mass change over the first 3 months of 
life. However, body surface area at birth was nega-
tively correlated with LV mass change (P<0.001). This 
was independent of the presence of maternal hy-
pertension. A similar relationship was seen between 
birthweight z-score and LV mass change (P<0.001). 
However, birthweight z- score was not associated 
with an increased LV mass indexed to body surface 
area at 3 months of age (P=0.37). This would suggest 
that babies that are smaller at birth show an accel-
erated growth postnatally but with a proportionately 
normal heart.
No other maternal, offspring, perinatal, or preg-
nancy factors were found to predict LV volume or 
mass differences during the first 3 months of life (Table 
S3) including infant sex. In bivariate analysis, the re-
duced RV volume at birth was associated with sev-
eral different factors related to severity of hypertensive 
pregnancy disorder including need for antihyperten-
sive treatment, classification of hypertensive disorder 
(Figure  3A), higher maximum maternal blood pres-
sure, higher maternal soluble endoglin (sENG) levels at 
birth, and a lower birthweight z- score (Table S4) with 
associations between duration of treatment in the 57 
women who required antihypertensive medication not 
reaching significance (P=0.18). Associations between 
RV end diastolic volume index and the use of labetalol 
(P=0.48) or the number of antihypertensive medica-
tions taken (P=0.08) were also not significant, although 
there was a nonsignificant negative trend with use of 
nifedipine (B coefficient −3.29  mL/m2, P=0.05 with 






Maternal demographics & anthropometrics
Maternal age at delivery, y 32.7±4.0 32.0±6.0
Body mass index at booking, 
kg/m2
23.1±3.5 26.7±5.1§
Booking sBP, mmHg 107.9±9.0 120.0±12.0§
Booking dBP, mmHg 64.8±8.0 73.5±10.3§
Smokers, n (%) 2 (4) 2 (3)
Gestational diabetes mellitus, 
n (%)
3 (6) 5 (6)
Offspring demographics & anthropometrics
Birth
Gestational age at delivery, wk 39.8±1.3 39.3±1.3†
Males, n (%) 29 (54) 30 (38)
Birth order* 1 (1) 1 (1)
Cesarean section, n (%) 14 (26) 22 (28)
Age at assessment, d 5.3±7.6 3.2±3.1
Birthweight, g 3433±529 3250±568
Birthweight z- score 0.28±1.0 0.10±1.2
Head circumference, cm 35.0±1.5 34.2±1.7‡
sBP, mmHg 82.6±13.8 81.1±13.1
dBP, mmHg 44.7±9.3 45.3±9.6
3mo
Age at assessment, d 99.6±14.8 96.7±13.1
Weight, g 6180±816 5974±937
Head circumference, cm 41.1±1.6 40.7±1.7
sBP, mmHg 96.3±11.7 97.6±12.6
dBP, mmHg 52.7±12.0 55.9±12.4
Booking blood pressure indicates the measurement taken during the 
first antenatal appointment in the first trimester of pregnancy; dBP, diastolic 
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model, only maximum systolic blood pressure re-
mained an independent predictor (Table 2). Increased 
RV mass at 3 months of age was also associated with 
factors related to the severity of hypertensive disease 
including higher booking blood pressure, higher maxi-
mum blood pressure, longer duration of hypertension, 
treatment with antihypertensives, and higher levels 
of sENG in the maternal circulation at birth (Table 3). 
However, the correlation with duration of antihyper-
tensive treatment and RV mass index at 3 months did 
not reach significance (P=0.07). There was also no as-
sociation with the use of labetalol (P=0.12), nifedipine 
Figure 2. A, Tukey boxplots demonstrating (i) LVMI and (ii) LVM /EDV at birth and (iii) LVMI and 
(iv) LVM/EDV at 3 months in term offspring born to normotensive and hypertensive pregnancies.
EDV indicates end diastolic volume; HTN, hypertensive pregnancy; LV left ventricle; LVMI, left ventricular 
mass index; and NT normotensive pregnancy. B, Tukey boxplots demonstrating (i) RVMI and (ii) RVM/
EDV at birth and (iii) RVMI and (iv) RVM/EDV at 3 months in term offspring born to normotensive and 
hypertensive pregnancies. EDV indicates end diastolic volume; HTN, hypertensive pregnancy; NT, 
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(P=0.57), or number of antihypertensive medications 
used (P=0.96). Delivery by cesarean section and a 
higher diastolic blood pressure in the offspring at 
3 months were also correlated with increased RV mass 
(Table S3). In a multivariable model of RV mass index 
at 3 months with pregnancy characteristics, levels of 
sENG and mode of delivery remained independent 
predictors of RV mass index, accounting for 43% of 
the variance (Table  4). Associations between preg-
nancy factors and RV structure and function were sim-
ilar in groups born to pregnancy- induced hypertension 
and preeclampsia (Figure 3B).
DISCUSSION
This study shows that infants born at term, after late- 
onset hypertensive pregnancy disorders, without sig-
nificant growth restriction, have altered RV structure at 
birth and go on to have a disproportionate increase 
in both LV and RV mass over the first 3  months of 
life, which are not associated with blood pressure 
changes. The changes in the RV, both at birth and 
3 months of age, are predicted by maternal features 
that describe the severity of the hypertensive disorder 
during pregnancy.
Increases in cardiac mass are seen early in the 
pathogenesis of hypertensive heart disease20–22 and 
can precede diagnosis of hypertension in children and 
adults who are at high risk because of a family his-
tory of high blood pressure.23–26 Pregnancy hyperten-
sion is considered a factor that places mothers and 
their offspring at high risk for hypertension,1–4,27 and 
in experimental models of pregnancy- induced hyper-
tension, the offspring display adverse changes to LV 
structure and function.28 However, human observa-
tional studies have been inconclusive and it has been 
difficult to disentangle the relative contribution of high 
blood pressure in the individual versus the history of 
Figure 3. A, Bar charts show a significant association between a reduction in right ventricular 
end diastolic volumes at birth and (i) severity or (ii) classification of the hypertensive disorder in 
the mother.
P values are presented as 1- way ANOVA test between groups. HTN indicates meds hypertensive- 
treated pregnancy; HTN, no meds untreated hypertensive; NT, normotensive; PET, preeclamptic; PIH, 
pregnancy- induced hypertension; and RVEDVI, right ventricular end diastolic volume index. B, Bar 
chart demonstrates increased right ventricular mass index at 3 months in offspring born to a pregnancy 
complicated by pregnancy- induced hypertension and preeclamptic pregnancies compared with those 
from normotensive pregnancies. NT indicates normotensive; PIH, pregnancy- induced hypertension; PET 
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hypertensive pregnancy, or other pregnancy compli-
cations, to any differences identified. In 1 study, no dif-
ferences in LV mass were evident in children born to 
hypertensive pregnancies compared with normoten-
sive pregnancies,10 but the study sample had a broad 
range of ages during adolescence, when there is sig-
nificant physiological variability in rate of increases in 
LV mass related to growth.29 A study focused on early 
adolescent children at age 12 years found those born 
to a hypertensive pregnancy had an increased cardiac 
mass but changes in LV mass were proportional to 
blood pressure.11 Our findings of changes in cardiac 
mass in infants born to hypertensive pregnancies are 
therefore consistent with some prior observations and 
raise the possibility that differences in later life may be 
caused by distinct trajectories for changes in cardiac 
mass, which start in the first few months of life and 
precede the development of significant hypertension.
Few studies have investigated RV changes, and we 
found the most significant and consistent differences 
were evident in this ventricle. The finding of a small 
right ventricular end diastolic volume at birth, which 
persists during infancy, raises the possibility that hy-
pertension during pregnancy has a disproportionately 
greater impact on RV development. In utero there is a 
RV- dominant circulation and therefore there may be 
relatively greater exposure of the RV to any adverse 
in utero hemodynamic changes. Preeclampsia is 
characterized by a poorly invaded placenta, which is 
likely to alter both fetal preload and afterload, and an 
altered systemic state with inflammation and oxidative 
stress.30,31 Such factors could induce RV fibrosis, lim-
iting ventricular growth or altering fetal vascular tone. 
Additionally, adverse exposures during a critical late 
fetal and perinatal period32 in both animal and human 
studies33,34 are able to alter pulmonary vascular de-
velopment, via an epigenetic- dependent pathway.9 
Adolescent offspring of preeclamptic pregnancies 
living at high altitudes have 30% higher pulmonary 
artery pressures8 as well as increased markers for 
oxidative stress. Their siblings born to normotensive 
pregnancies had normal vascular function, supporting 
a specific impact of pregnancy hypertension on the 
developing vasculature. We did not have measures of 
pulmonary pressure, or placental vascular resistance, 
in our study group, which is a potential limitation. 
Table 2. Multivariable Linear Regression of Right 
Ventricular End Diastolic Volume Index at Birth With 
Maternal, Offspring, and Pregnancy Characteristics
RVEDVI Birth
B 95% CI P Value
Maternal age at 
delivery, y
0.10 −0.20 to 0.40 0.51
Maximum sBP, mm Hg −0.15 −0.29 to −0.01 0.03*
Treatment with antihypertensives
No Reference
Yes −1.67 −7.67 to 4.34 0.58
sENG levels, ng/mL 0.01 −0.29 to 0.31 0.93
Birthweight z- score 0.19 −1.56 to 1.93 0.83
TVD change, % −0.01 −0.13 to 0.10 0.82
sENG indicates soluble endoglin; RVEDVI, right ventricular end diastolic 
volume index; sBP, systolic blood pressure; and TVD, total vessel density.
*P<0.05.
Table 3. Bivariate Linear Regression Coefficients of RVMI 
at 3 Months With Characteristics of Hypertensive Disease
RVMI 3 months
B 95% CI P Value
Severity of hypertension
Booking sBP, mmHg 0.12 −0.04 to 0.20 0.005*
Booking dBP, mmHg 0.15 0.05–0.24 0.003*
Maximum sBP, mmHg 0.09 0.04–0.13 <0.001*
Maximum dBP, mmHg 0.12 0.05–0.20 0.001*
Duration of hypertension, wk 0.64 0.10–1.17 0.02*
Treatment with antihypertensives
No Reference
Yes 2.23 0.15–4.30 0.04*
sFlt- 1 levels, pg/mL 0.001 0.00–0.002 0.12
sENG levels, ng/mL 0.30 0.17–0.43 <0.001*
PlGF levels, pg/mL 0.05 −0.02 to 0.11 0.15
VEGF levels, pg/mL −0.003 −0.03 to 0.03 0.83
sFlt- 1/PlGF ratio 0.11 −0.002 to 0.024 0.08
dBP indicates diastolic blood pressure; PlGF, placental growth factor; 
RVMI, right ventricular mass index; sBP, systolic blood pressure; sENG, 
soluble endoglin; sFlt- 1, soluble fms- like tyrosine kinase- 1; and VEGF, 
vascular endothelial growth factor.
*P<0.05.
Table 4. Multivariable Linear Regression Coefficients of 
RVMI at 3 Months With Pregnancy Characteristics
RVMI 3 months
B 95% CI P Value
Maternal age at delivery, y −0.67 −0.27 to 0.14 0.52
Booking sBP, mm Hg −0.03 −0.3 to 0.07 0.57
Maximum sBP, mm Hg 0.06 −0.03 to 0.16 0.17
Duration of hypertension, wk 0.44 −0.14 to 1.01 0.13
Treatment with antihypertensives
No Reference
Yes −0.67 −3.99 to 2.66 0.69
sENG levels, ng/mL 0.19 0.02–0.36 0.03*
Cesarean section
No Reference
Yes 3.40 0.99–5.90 0.007*
RVMI indicates right ventricular mass index; sBP, systolic blood pressure; 
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Recently, a novel noninvasive index using echocar-
diography in children has been developed that mea-
sures RV coupling with the pulmonary vasculature.35 
However, because there is variability in pulmonary he-
modynamics over the first few months of life because 
of postnatal transition, estimates of these measures 
using echocardiography may not have been reliable at 
follow- up.36 Nevertheless, the presence of pulmonary 
vascular changes in combination with altered myocar-
dial efficiency, because of reduced RV end diastolic 
volumes, might account for the postnatal increase 
in RV mass after the opening of the pulmonary cir-
culation. Further longitudinal follow- up of this cohort, 
which would include detailed multimodality assess-
ment of cardiovascular structure including atrial size 
and the pulmonary vasculature, is warranted. We, and 
others, have previously demonstrated that the sys-
temic microvasculature differs in offspring of hyperten-
sive pregnancies,5,6 which is likely to alter LV afterload, 
and could explain the parallel increases in postnatal LV 
mass observed in the study group.
To further test whether pregnancy hypertension 
was associated with cardiac development, we studied 
whether there were graded associations between se-
verity of hypertension in pregnancy and the changes 
in the offspring at birth, taking into account other fac-
tors such as gestational age and birthweight. Indeed, 
RV volume reductions at birth were more severe in 
those born following preeclampsia than pregnancy- 
induced hypertension, but this classification did not 
predict differences in mass. This may be because 
although preeclampsia and pregnancy- induced hy-
pertension have a different underlying pathophys-
iology, it can often be difficult in a clinical situation 
to distinguish the two.37 Therefore, we opted to use 
continuous measures of pregnancy severity including 
maximum blood pressure level and circulating sENG 
across the cohort for our analyses. When these were 
used, cardiac changes were proportional to mark-
ers of disease severity, with associations extending 
to RV measures at 3 months of age. In multivariable 
models, other associations, such as mode of delivery, 
appeared to be because of their co- association with 
pregnancy disorder, rather than reflecting an inde-
pendent influence.
Because preeclampsia is often associated with a 
host of changes in the offspring including suppres-
sion of fetal growth in addition to a maternal anti-
angiogenic profile,37 our findings may suggest it has 
greater influence on offspring cardiac remodeling 
compared with pregnancy- induced hypertension. 
However, increased rates of hypertrophy and reduced 
function are reported in mothers after all types of hy-
pertensive pregnancies.38 Our hypothesis was that 
an antiangiogenic profile in the maternal circulation 
did not directly cause changes in the fetus, merely 
that it was a surrogate marker for a hostile, in utero 
environment that may subsequently lead to adverse 
changes in the fetus. In support of this, Zafer et al. 
found correlation between maternal serum but not 
amniotic fluid levels of anti- angiogenic markers and 
uterine artery dopplers measured using ultrasound.39 
The association between sENG and fetal cardiovas-
cular measures is intriguing. We have previously 
shown links between the maternal antiangiogenic 
profile and vascular development in the offspring 
postnatally,5 and it may be that an additional prenatal 
impact on placental development alters fetal vascular 
load resulting in distinct patterns of myocardial devel-
opment, as previously shown in animal physiology.40 
There are also strong maternal–offspring correlations 
in LV mass,41 and a shared, familial, cardiovascular 
phenotype between mother and offspring may ex-
plain some of these findings. In addition, both pre-
eclampsia and pregnancy- induced hypertension 
have been shown to affect uterine blood flow, which 
may be a possible common pathway for the 2 condi-
tions resulting in fetal cardiac remodeling.42
Another potential limitation is our use of semi- 
automated software to derive measures from sin-
gle 4- chamber views. Neonatal echocardiography is 
technically challenging, so our use of a single plane 
increased data capture and allowed standardized, re-
peated measures during postnatal life. Assumptions 
about ventricular geometry in the analysis means 
absolute mass measures should be interpreted cau-
tiously but, because similar assumptions were made 
across the cohort, with good reproducibility, between- 
group differences are likely to be present. The com-
plex shape of the RV makes it difficult to analyze but 
single- plane measurements have been reported18 and, 
as there are limited reports of RV changes, our findings 
add novel data to the literature. The images were op-
timized for the LV and we were not able to acquire RV 
measurements in the whole cohort, which may have 
introduced a degree of bias. Therefore, replication of 
our findings in other cohorts will be of value. However, 
the repeatability of our RV measurements was high 
(Data S1) so it is unlikely our results are attributable 
to chance based on the magnitude of the differences.
In summary, we have demonstrated differences in 
ventricular structure at birth in term- born offspring of 
hypertensive pregnancies, which is most pronounced 
for the RV. These structural differences precede a dis-
proportionate increase in both RV and LV mass over 
the first 3 months of life. Further work will be of value to 
establish whether differences persist into later life and 
whether they impact physical or respiratory function, 
as well as later cardiac risk. The RV changes were pro-
portional to the severity of the hypertensive disease, 
and to what extent hypertensive pregnancy manage-
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during pregnancy can mitigate cardiac changes in the 
offspring requires further investigation.
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A stratified recruitment approach to ensure balanced representation of preterm and term birth 
as well as hypertensive and normotensive pregnancies was employed through the EPOCH 
(Effect of Preterm birth and pregnancy Hypertension on Offspring Cardiovascular Health) 
study (South Central Berkshire Research Ethics Committee ref. 11/SC/0006, 
UKCRN/clinical trials ref. NCT01888770)5. On designated days of the week, consecutive 
women who had delivered preterm and/or who had experienced a hypertensive pregnancy 
were approached to take part in the study. A subgroup of women who had experienced a 
term, normotensive pregnancy delivering on the same day were also approached. In total 255 
infants were recruited and underwent echocardiography soon after birth and at three months 
of age. Of these, 134 were born at term (after 37 weeks gestation) and form the cohort used 
for this study.  
 
Inclusion and exclusion criteria 
 
Singletons and multiplets were included. Mothers below the age of 16 years were excluded 
from the study as were those with chronic cardiovascular conditions prenatally, including 
essential hypertension. Infants were excluded if they had evidence of any severe 
malformations, congenital cardiovascular disease, chromosomal abnormalities or genetic 
disorders but those with persistent features of a fetal circulation at birth i.e. Patent Ductus 
Arteriosus (PDA) and/or Atrial Septal Defect (ASD)) were included. 
 
Clinical data collection and study measures 
Characterisation of pregnancy complications and perinatal data related to the clinical care of 
the infant was extracted from medical records retrospectively in a standardised way across 








defined at first trimester ultrasound and preterm birth was defined as any birth before 37 
weeks gestation. Hypertensive pregnancy diagnosis (pregnancy induced hypertension, 
preeclampsia) was defined according to ISSHP guidelines16. Women with essential 
hypertension were excluded from the study. At both the birth and three month assessments, 
weight was measured using digital scales (Charder Model MS4200) to the nearest 0.01kg 
with the infant fully naked. Z-scores for weight were calculated using the International 
Standard size at birth reference charts from the INTERGROWTH-21st Project36, 37 using their 
online application (https://intergrowth21.tghn.org/global-perinatal-package/intergrowth-21st-
comparison-application/). At birth and three months, three blood pressure measurements were 
recorded on the right calf, known to be comparable to arm measurements in neonates,38 with 
an automated digital monitor (Dinamap technology® V100) using appropriate sized cuffs and 
were averaged for analysis. Investigators performing the assessments were not blinded to 
participant group, but those involved in image analysis were.  
Quantification of cardiac mass and volume - Cineloops were acquired with ECG tracing for 
gating. Mass and volume estimates were obtained by manual contouring of the endo and 
epicardium using TomTec Image Arena 4.6 from the apical four chamber view for fetal, 
neonatal and infant echocardiography. The end diastolic frame was manually selected using 
the point of mitral valve closure as the marker and contours manually set at the inner 
endocardial edge and outer epicardial edge within the onset of the pericardium. To maximise 
reproducibility, the entirety of the septum was contoured for both LV and right ventricular 
(RV) measurements. Ventricular mass and volumes were adjusted for body size based on 
estimated body surface area (BSA), using the Boyd formula 39 and these values are reported 
as mass, or volume, index. To assess inter and intraobserver variability for measures, 10 
datasets were selected at random (i.e. not selected for image quality) from neonatal datasets 








Coefficients (ICC) for single measures with 95% confidence intervals for intra and inter-
observer variability yielded 1.00 (0.98-1.00) and 0.97 (0.83-0.99) for postnatal LV mass and 
0.96 (0.84-0.99) and 0.81 (0.41-0.95) for postnatal RV mass respectively.  
Quantification of Ventricular Systolic and Diastolic Function - LV systolic parameters 
including ejection fraction, stroke volume and cardiac output were captured from automated 
tracking of the contours of the endocardium using TomTec Image Arena 4.6 as above. 
Manual adjustments of the contours were made, as required, throughout the cardiac cycle to 
ensure appropriate tracking of all segments and excluded if this was not possible due to 
image quality. RV systolic function was quantified by taking an M-Mode slice through the 
tricuspid annulus using the cursor in real time to measure the tricuspid annular plane systolic 
excursion (TAPSE), analysed offline using Philips Xcelera 3.3. At birth and three month 
follow up, routine diastolic function parameters were assessed. Pulsed wave Doppler was 
measured from the mitral valve tips to assess early and late diastolic inflow and the ratio of 
these flows were characterised as E/A ratio using Philips Xcelera 3.3. Further Doppler 
interrogation of the lateral mitral valve annulus using Tissue Doppler Imaging was measured 
in early diastole (E’) and was utilised in the ratio of early diastolic flow to early diastolic 
tissue velocity (E/E’) to assess myocardial relaxation in relation to the filling velocities. 10 
datasets were again selected at random and the ICC for single measures with 95% confidence 
intervals for intra and inter-observer variability were as follows: 0.99 (0.95-1.00) and 0.98 
(0.94-1.00) for E/A ratio; 1.00 (1.00-1.00) and 0.93 (0.97-1.00) for lateral E’; 0.97 (0.87-
0.99) and 0.90 (0.64-0.97) for TAPSE. 
Angiogenic marker quantification - Blood samples were collected from the mother 
postnatally, centrifuged and separated within 30 minutes for storage at -80oC pending 
analysis. Plasma circulating vascular endothelial growth factor A (VEGF-A or VEGF165), 








endoglin (sENG) concentrations were quantified with commercial enzyme-linked 
immunosorbent assays (ELISAs) (Quantikine, R&D Systems Europe, Abingdon, UK). All 
samples, standards, and controls were plated in duplicate. Optical density of each well was 
measured at 450nm using a FLUOstar Omega microplate reader (BMG Labtech, 
KBioScience, USA). Data was analyzed using Omega Data Analysis software. Duplicate 
readings for each standard, control, and sample were averaged, and the average zero standard 
optical density was subtracted. Standard curves were created by generating a four-parameter 




















Maternal Demographics & 
Anthropometrics 
   
Maternal age at delivery, years 32.7±4.0 32.6±5.3 31.4±6.6 
Body Mass Index at booking, kg/m2 23.1±3.5 27.4±5.1# 25.9±5.0§ 
Booking sBP, mmHg 108±9 122±11# 117±13# 
Booking dBP, mmHg 65±8 74±9# 73±11# 
     Smokers, n (%) 2(4) 1(2) 1(3) 
     Gestational Diabetes, n (%) 3 (6) 3 (7) 2 (5) 
Offspring Demographics & 
Anthropometrics 
   
Birth    
     Gestational age at delivery, weeks 39.8±1.3 39.7±1.1 38.8±1.3†# 
     Males, n (%) 29(54) 12(28)§ 18(49) 
     Birth order** 1(1) 1(1) 1(1) 
     Caesarean section, n (%) 14(26) 11(26) 11(30) 
     APGARS at 5 minutes 10±0.19 10±0.21 10±0.62 
Age at assessment, days 5.3±7.6 3.3±4.1 2.9±1.5 
Birthweight, grams 3433±529 3443±554 3025±504†# 
Birthweight z-score 0.28±1.0 0.43±1.2 -0.29±1.0*§ 
Head circumference, cms 35.0±1.5 34.9±1.6 33.5±1.5‡# 
sBP, mmHg 82.6±13.8 81.8±13.2 80.3±13.1 










3 Months    
Age at assessment, days 99.6±14.8 95.3±13.9 98.2±12.2 
Weight, grams 6180±816 6063±958 5873±918 
Head circumference, cms 41.1±1.6 40.9±1.6 40.5±1.7 
sBP, mmHg 96.3±11.7 95.6±12.5 99.8±12.5 
dBP, mmHg 52.7±12.0 54.4±12.9 57.6±11.7 
 
Comparison of PIH and PET group *p<0.05; †p<0.01; ‡p<0.001 
Comparison to NT group §p<0.05; ||p<0.01; #p<0.001 
**Median (interquartile range) 
sBP indicated systolic blood pressure; dBP diastolic blood pressure; PIH pregnancy 








Table S2. Cardiac Structure and Function. 
 Birth Follow Up 
NT HTN p-value NT HTN p-value 
Left Ventricle n=48 n=69  n=48 n=62  
  Volumes       
EDV (ml) 4.6±1.2 4.0±1.2 0.02 9.6±2.0 9.0±2.0 0.11 
     EDV Index (ml/m2) 19.4±4.5 17.9±4.1 0.06 27.5±4.6 26.4±5.2 0.25 
   Mass       
      Mass (g) 4.9±1.2 4.6±1.2 0.18 8.7±1.6 9.1±1.9 0.17 
 Mass Index (g/m2) 20.9±3.7 20.6±4.0 0.64 24.9±4.6 26.8±4.9 0.04 
      Mass/EDV 1.1±0.2 1.2±0.3 0.11 0.9±0.2 1.0±0.2 0.003 
  Function       
   Systolic Function       
  Ejection fraction (%) 62.2±9.4 64.8±7.6 0.13 59.1±7.2 60.0±8.8 0.65 
       Stroke Volume (ml) 2.8±0.7 2.6±0.7 0.27 5.8±1.3 6.9±8.0 0.49 
    Diastolic Function       
       EA 1.0±0.3 1.1±0.3 0.83 1.0±0.2 1.0±0.2 0.40 
       Lateral E’ 6.8±1.5 6.5±1.8 0.49 10.2±2.0 10.3±2.2 0.77 
       Lateral E/E’ ratio 8.0±2.3 7.8±2.7 0.69 8.3±3.0 8.0±2.3 0.84 
  Right Ventricle n=32 n=44  n=34 n=41  
   Volumes       
      EDV (ml) 3.9±1.5 2.9±1.2 0.001 5.8±1.4 5.1±1.9 0.06 
      EDV Index (ml/m2) 16.8±5.3 12.7±4.7 0.001 16.4±3.2 14.4±4.8 0.04 
   Mass       










 Mass Index (g/m2) 17.5±3.7 18.1±4.7 0.57 17.1±4.2 21.1±3.9 <0.001 
 Mass/EDV 1.1±0.5 1.5±0.4 <0.001 1.1±0.3 1.6±0.7 <0.001 
   Function       
      TAPSE 0.89±0.2 0.86±0.2 0.36 1.5±0.3 1.5±0.3 0.65 
 
EDV indicates end diastolic volume; TAPSE tricuspid annular plane systolic excursion; NT 








Table S3. Bivariate Linear Regression Coefficients of Right and Left Ventricular Mass 
Index at 3 months with Maternal, Offspring and Pregnancy Characteristics.  
 LVMI 3months RVMI 3 months 
B 95% CI p-value B 95% CI p-value 
Maternal factors       
Maternal BMI, (kg/m2) 0.06 -0.13-0.26 0.53 0.17 -0.04-0.38 0.11 
Severity of HTN       
Booking sBP,mmHg 0.004 -0.08-0.08 0.92 0.12 -0.04-0.20 0.005 
Booking dBP, mmHg 0.06 -0.03-0.15 0.19 0.15 0.05-0.24 0.003 
Maximum sBP, mmHg 0.04 -0.001-0.09 0.06 0.09 0.04-0.13 <0.001 
Maximum dBP, mmHg 0.05 -0.02-0.11 0.17 0.12 0.05-0.20 0.001 
Duration of HTN, weeks 0.27 -0.12-0.66 0.18 0.64 0.10-1.17 0.02 
Treatment with anti-
hypertensives 
      
     No Reference      
     Yes 1.57 -0.29-3.43 0.10 2.23 0.15-4.30 0.04 
sFlt-1 levels, pg/mL -9.84E-005 -0.001-0.001 0.83 0.001 0.00-0.002 0.12 
sENG levels, ng/mL 0.07 -0.11-0.24 0.43 0.30 0.17-0.43 <0.001 
PlGF levels, pg/mL 0.003 -0.08-0.09 0.94 0.05 -0.02-0.11 0.15 
VEGF levels, pg/mL 0.008 -0.02-0.04 0.63 -0.003 -0.03-0.03 0.83 
sFlt-1/PlGF ratio -0.006 -0.23-0.010 0.46 0.11 -0.002-0.024 0.08 
Perinatal factors       
Caesarean section       
     No Reference      








Sex -0.56 -2.41-1.29 0.55 1.38 -0.69-3.44 0.19 
     Male Reference      
     Female -0.56 -2.41-1.29 0.55 1.38 -0.69-3.44 0.19 
Birthweight z-score -0.37 -1.17-0.43 0.37 -0.09 -1.08-0.90 0.85 
APGARS at 5 mins -1.96 -5.08-1.16 0.22 -1.17 -4.14-1.80 0.43 
Infections -1.26 -6.17-3.64 0.61 2.58 -3.85-9.01 0.43 
     No Reference      
     Yes -1.26 -6.17-3.64 0.61 2.58 -3.85-9.01 0.43 
Days of oxygen 1.52 -1.40-4.44 0.31 -1.03 -3.90-1.84 0.48 
TVD change (%) -0.06 -0.12- -0.003 0.04 -0.04 -0.10-0.02 0.22 
Vascular measures       
sBP at birth, mmHg 0.002 -0.07-0.07 0.96 -0.01 -0.09-0.07 0.76 
dBP at birth, mmHg 0.02 -0.08-0.11 0.72 -0.01 -0.12-0.10 0.86 
sBP at 3 months, mmHg 0.009 -0.07-0.09 0.82 0.07 -0.02-0.16 0.13 
dBP at 3 months, mmHg -0.03 -0.11-0.05 0.44 0.09 0.007-0.18 0.04 
PWV at birth, m/sec 0.06 -0.39-0.51 0.79 -0.18 -0.64-0.29 0.45 
PWV at 3 months, m/sec -0.21 -0.76-0.33 0.44 0.24 -0.31-0.79 0.39 
 
BMI indicates body mass index; sBP systolic blood pressure, dBP diastolic blood pressure; HTN 
hypertension;  sFlt-1soluble fms-like tyrosine kinase-1; sENG soluble endoglin, PlGF placental 
growth factor, VEGF vascular endothelial growth factor; TVD total vessel density; PWV pulse wave 









Table S4. Bivariate Linear Regression Coefficients for Right Ventricular End Diastolic 
Volume Index at birth with Maternal, Offspring and Pregnancy Characteristics.  
 RVEDVI Birth 
B 95% CI p-value 
Maternal factors    
Maternal BMI, kg/m2 -0.07 -0.35-0.22 0.64 
Severity of HTN    
Booking sBP, mmHg -0.07 -0.20-0.05 0.25 
Booking dBP, mmHg -0.04 -0.19-0.10 0.53 
Maximum sBP, mmHg -0.09 -0.15- -0.02 0.009 
Maximum dBP, mmHg -0.20 -0.30- -0.09 <0.001 
Duration of HTN, weeks -0.60 -1.38-0.19 0.13 
Treatment with anti-
hypertensives 
   
     No Reference   
     Yes -4.94 -7.74- -2.15 0.001 
sFlt-1 levels, pg/mL 0.00 -0.002-0.001 0.83 
sENG levels, ng/mL -0.30 -0.55- -0.05 0.02 
PlGF levels, pg/mL 0.11 -0.24-0.46 0.52 
VEGF levels, pg/mL -0.009 -0.05-0.04 0.68 
sFlt-1/PlGF ratio -0.005 -0.031-0.021 0.72 
Perinatal factors    








     No Reference   
     Yes -0.97 -4.47-2.53 0.58 
Sex -0.71 -3.74-2.33 0.64 
     Male Reference   
     Female -0.71 -3.74-2.33 0.64 
Birthweight z-score 1.92 0.58-3.27 0.006 
Apgars at 5 mins 0.24 -3.82-4.30 0.91 
Postnatal infections    
     No Reference   
     Yes 4.51 -3.30-12.32 0.25 
Need for oxygen    
     No Reference   
     Yes 0.08 -11.00-11.17 0.99 
TVD change, % 0.11 0.02-0.19 0.02 
Vascular measures    
sBP at birth, mmHg 0.004 -0.11-0.12 0.94 
dBP at birth, mmHg -0.04 -0.21-0.12 0.60 
sBP at 3 months, mmHg -0.02 -0.13-0.10 0.80 
dBP at 3 months, mmHg -0.02 -0.15-0.11 0.76 
PWV at birth, m/s -0.30 -0.97-0.36 0.36 
PWV at 3 months, m/s -0.42 -1.23-0.38 0.29 
BMI indicates body mass index; sBP systolic blood pressure, dBP diastolic 
blood pressure; HTN hypertension;  sFlt-1soluble fms-like tyrosine kinase-1; 
sENG soluble endoglin, PlGF placental growth factor, VEGF vascular 
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